Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of candesartan, once daily (QD),
combined with hydrochlorothiazide to lower blood pressure in insulin-resistant, obese
patients with hypertension.